Singzyme is a pioneering brand at the forefront of groundbreaking technology in the field of peptide conjugation. With their versatile platform, Singzyme utilizes their patented Peptide Asparaginyl Ligases (PAL) technology to offer a range of innovative products and services.

Singzyme's PAL technology enables site-specific conjugation using peptide ligases, providing a family of enzymes for combinatorial conjugation. This breakthrough technology boasts a reaction speed that is 20,000 times faster than other enzymes, with a minimal impact on the final product, including low interference with antibody activity and tumor penetration.

With Singzyme, the possibilities are endless. Their technology supports various types of applications, allowing for the conjugation of any target and any type of payload. Whether it's Antibody Drug Conjugates, cytotoxic molecules, immuno-stimulants, radioelements, or nanobodies for tumor diagnosis and personalized treatment, Singzyme has you covered.

In addition to their comprehensive offerings, Singzyme also specializes in other bioconjugates, including Antibody RNA Conjugates, Antibody DNA Conjugates, enzyme conjugation, and nanoparticle conjugation. They offer solutions for a range of industries, including healthcare, diagnostics, and research.

Trust Singzyme's strong science, backed by an expert Management Board of Directors and Scientific Advisory Board. Stay up-to-date with the latest news and advancements in the field while getting in touch with Singzyme's dedicated team via their contact information.

Choose Singzyme for cutting-edge technology, exceptional service, and unparalleled expertise in peptide conjugation.